- 2.9Impact Factor
- 5.2CiteScore
- 18 daysTime to First Decision
Special Issues
Journal of Clinical Medicine publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Clinical Advances in the Pharmacotherapy of Diabetes
Deadline: 20 June 2026
Clinical Pharmacology: Adverse Drug Reactions
Deadline: 25 May 2026
Innovations and Challenges in Clinical Toxicology and Therapeutic Drug Monitoring
Deadline: 25 April 2026
Updates in the Use of Pharmacogenetics in Clinical Practice
Deadline: 20 March 2026
Recent Advances in Clinical Pharmacology Based on Pharmacokinetics
Deadline: 25 February 2026
Drug-Related Problems: Clinical Pharmacy and Safety of Pharmacotherapy
Deadline: 15 February 2026
Research and Applications in Clinical Pharmacy Based on Pharmacokinetics and Pharmacogenetics
Deadline: 25 November 2025
Chronicity, Multimorbidity, and Medication Appropriateness
Deadline: 30 June 2025
Advances in Drugs and Therapy for Cardiovascular Disease: From the Researcher's Desk to the Patient's Bedside
Deadline: 29 November 2024
COVID-19 Treatments and Therapeutics
Deadline: 31 May 2024
Pharmacoepidemiology in Clinical Research
Deadline: 30 September 2023
Clinical, Translational and Experimental Pharmacotherapeutics Advances
Deadline: 20 September 2023
of 3

